Skip to main content

Advertisement

Log in

Symptomatic Exposures Among California Inmates 2011–2013

  • Toxicology Investigation
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Prisoners have a high prevalence of substance misuse and abuse, but few studies have examined symptomatic exposures among incarcerated populations. We sought to further characterize the nature of these exposures among this population using the California Poison Control System data. Keyword searches identified inmate cases in 2011–2013 for patients 20+ years old exposed to a single substance and taken to hospital from jail, prison, or police custody. Comparisons were made with non-inmate cases during the same period, using similar limitations. Body stuffers and body packers were analyzed as a subgroup. Seven hundred four inmate cases were compared to 106,260 non-inmate cases. Inmates were more likely to be younger, male, and to have engaged in drug misuse or abuse. They most commonly ingested methamphetamine, heroin, acetaminophen, and anticonvulsants. Inmates were more likely to receive activated charcoal (OR 9.87, 8.20–11.88), whole bowel irrigation (OR 44.50, 33.83–58.54), undergo endotracheal intubation (OR 4.09, 2.91–5.73), and to experience a major clinical outcome or death (OR 1.41, 1.05–1.89). When body stuffers and packers were removed, clinical findings were similar, though the odds of a major outcome or death became statistically non-significant. Body stuffers and body packers primarily used methamphetamine and heroin, and compared with other inmates had significantly higher odds of both adverse clinical effects and poor outcome. This large series provides a profile of symptomatic exposures among inmates, a little-studied population. The potential for high morbidity among body stuffers and packers suggests that a high index of suspicion of such ingestions be maintained when evaluating patients prior to incarceration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bureau of Justice Statistics USD of J Correctional populations in the United States. 2012.

  2. Leukefeld CG, Tims FR (1993) Drug abuse treatment in prisons and jails. J Subst Abuse Treat 10:77–84. doi:10.1016/0740-5472(93)90103-9

    Article  CAS  PubMed  Google Scholar 

  3. Mumola C. Substance abuse and treatment, state and federal prisoners, 1997.

  4. Mumola C, Karberg J. Drug use and dependence, state and federal prisoners, 2004. United States Department of Justice. 2006.

  5. Malcolm AH. Explosive drug use creating new underworld prisons. N. Y. Times. 1989.

  6. Inciardi JA, Lockwood D, Quinlan JA. Drug use in prison: patterns, processes, and implications for treatment. J. Drug Issues. 1993;23.

  7. Wohl AR, Johnson D, Jordan W et al (2000) High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr 24:386–92

    Article  CAS  PubMed  Google Scholar 

  8. Clarke JG, Stein MD, Hanna L et al (2001) Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abuse 22:209–16. doi:10.1080/08897070109511463

    Google Scholar 

  9. Prendergast ML, Campos M, Farabee D et al (2004) Reducing substance use in prison: the California department of corrections drug reduction strategy project. Prison J 84:265–80. doi:10.1177/0032885504265485

    Article  Google Scholar 

  10. Del Paggio D. Psychotropic medication abuse in correctional facilities. Bay Area Psychopharmacol Newsl. 2005;1,5,6.

  11. Andía JF, Deren S, Robles RR et al (2005) Factors associated with injection and noninjection drug use during incarceration among Puerto Rican drug injectors in New York and Puerto Rico. Prison J 85:329–42. doi:10.1177/0032885505279373

    Article  Google Scholar 

  12. Rowell TL, Wu E, Hart CL et al (2012) Predictors of drug use in prison among incarcerated black men. Am J Drug Alcohol Abuse 38:593–7. doi:10.3109/00952990.2012.694536

    Article  PubMed Central  PubMed  Google Scholar 

  13. Vugia DJ, Mase SR, Cole B et al (2009) Botulism from drinking pruno. Emerg Infect Dis 15:69–71. doi:10.3201/eid1501.081024

    Article  PubMed Central  PubMed  Google Scholar 

  14. Centers for Disease Control and Prevention (CDC) (2012) Botulism from drinking prison-made illicit alcohol—Utah 2011. MMWR Morb Mortal Wkly Rep 61:782–4

    Google Scholar 

  15. Roberts JR, Price D, Goldfrank L, Hartnett L (1986) The bodystuffer syndrome: a clandestine form of drug overdose. Am J Emerg Med 4:24–7

    Article  CAS  PubMed  Google Scholar 

  16. Traub SJ, Hoffman RS, Nelson LS (2003) Body packing—the internal concealment of illicit drugs. N Engl J Med 349:2519–26. doi:10.1056/NEJMra022719

    Article  CAS  PubMed  Google Scholar 

  17. Salive ME, Smith GS, Brewer TF (1990) Death in prison: changing mortality patterns among male prisoners in Maryland, 1979–87. Am J Public Health 80:1479

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Kim S, Ting A, Puisis M et al (2006) Deaths in the cook county jail: 10-year report, 1995–2004. J Urban Health 84:70–84. doi:10.1007/s11524-006-9115-9

    Article  PubMed Central  Google Scholar 

  19. Spaulding AC, Seals RM, McCallum VA et al (2011) Prisoner survival inside and outside of the institution: implications for health-care planning. Am J Epidemiol 173:479–87. doi:10.1093/aje/kwq422

    Article  PubMed Central  PubMed  Google Scholar 

  20. Patterson RF, Hughes K (2008) Review of completed suicides in the California Department of Corrections and Rehabilitation, 1999 to 2004. Psychiatr Serv Wash DC 59:676–82. doi:10.1176/appi.ps.59.6.676

    Article  Google Scholar 

  21. Hayes LM (2012) National study of jail suicide: 20 years later. J Correct Health Care Off J Natl Comm Correct Health Care 18:233–45. doi:10.1177/1078345812445457

    Article  Google Scholar 

  22. Data Analysis Unit, California Department of Corrections and Rehabilitation. Weekly Report of Population. 2012.

  23. California Poison Control System. The difference: California Poison Control System. Annual Report 2009. 2009.

  24. Mowry JB, Spyker DA, Cantilena LR Jr et al (2013) 2012 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th annual report. Clin Toxicol Phila Pa 51:949–1229. doi:10.3109/15563650.2013.863906

    Article  CAS  Google Scholar 

  25. Jewell N. Statistics for epidemiology. Chapman & Hall. 2003.

  26. Fazel S, Bains P, Doll H (2006) Substance abuse and dependence in prisoners: a systematic review. Addict Abingdon Engl 101:181–91. doi:10.1111/j.1360-0443.2006.01316.x

    Article  Google Scholar 

  27. Plugge E, Yudkin P, Douglas N (2009) Changes in women’s use of illicit drugs following imprisonment. Addict Abingdon Engl 104:215–22. doi:10.1111/j.1360-0443.2008.02419.x

    Article  Google Scholar 

  28. Burke C (2007) Methamphetamine use among San Diego county arrestees. J Psychoactive Drugs Suppl 4:337–45

    Article  Google Scholar 

  29. Gonzales R, Mooney L, Rawson RA (2010) The methamphetamine problem in the United States. Annu Rev Public Health 31:385–98. doi:10.1146/annurev.publhealth.012809.103600

    Article  PubMed Central  PubMed  Google Scholar 

  30. Steinberg JK, Grella CE, Boudov MR et al (2011) Methamphetamine use and high-risk sexual behaviors among incarcerated female adolescents with a diagnosed STD. J Urban Health Bull N Y Acad Med 88:352–64. doi:10.1007/s11524-011-9557-6

    Article  Google Scholar 

  31. Hendrickson RG, Cloutier R, McConnell KJ (2008) Methamphetamine-related emergency department utilization and cost. Acad Emerg Med Off J Soc Acad Emerg Med 15:23–31. doi:10.1111/j.1553-2712.2007.00006.x

    Article  Google Scholar 

  32. Schep LJ, Slaughter RJ, Beasley DMG (2010) The clinical toxicology of metamfetamine. Clin Toxicol Phila Pa 48:675–94. doi:10.3109/15563650.2010.516752

    Article  CAS  Google Scholar 

  33. Olson KR. Chapter 38. Poisoning. Curr. Med. Diagn. Treat. 2014.

  34. Karch SB, Stephens BG (1999) Drug abusers who die during arrest or in custody. J R Soc Med 92:110

    PubMed Central  CAS  PubMed  Google Scholar 

  35. Albertson TE, Derlet RW, Van Hoozen BE (1999) Methamphetamine and the expanding complications of amphetamines. West J Med 170:214–9

    PubMed Central  CAS  PubMed  Google Scholar 

  36. Kaye S, Darke S, Duflou J, McKetin R (2008) Methamphetamine-related fatalities in Australia: demographics, circumstances, toxicology and major organ pathology. Addict Abingdon Engl 103:1353–60. doi:10.1111/j.1360-0443.2008.02231.x

    Article  Google Scholar 

  37. Chan P, Chen JH, Lee MH, Deng JF (1994) Fatal and nonfatal methamphetamine intoxication in the intensive care unit. J Toxicol Clin Toxicol 32:147–55

    Article  CAS  PubMed  Google Scholar 

  38. Kaye S, McKetin R, Duflou J, Darke S (2007) Methamphetamine and cardiovascular pathology: a review of the evidence. Addict Abingdon Engl 102:1204–11. doi:10.1111/j.1360-0443.2007.01874.x

    Article  Google Scholar 

  39. Binswanger IA, Stern MF, Deyo RA et al (2007) Release from prison—a high risk of death for former inmates. N Engl J Med 356:157–65. doi:10.1056/NEJMsa064115

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. West PL, McKeown NJ, Hendrickson RG (2010) Methamphetamine body stuffers: an observational case series. Ann Emerg Med 55:190–7. doi:10.1016/j.annemergmed.2009.08.005

    Article  PubMed  Google Scholar 

  41. Sporer KA, Firestone J (1997) Clinical course of crack cocaine body stuffers. Ann Emerg Med 29:596–601

    Article  CAS  PubMed  Google Scholar 

  42. June R, Aks SE, Keys N, Wahl M (2000) Medical outcome of cocaine bodystuffers. J Emerg Med 18:221–4

    Article  CAS  PubMed  Google Scholar 

  43. Moreira M, Buchanan J, Heard K (2011) Validation of a 6-hour observation period for cocaine body stuffers. Am J Emerg Med 29:299–303. doi:10.1016/j.ajem.2009.11.022

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of Interest

The authors declare no conflicts of interest.

Sources of Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael Butterfield.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Butterfield, M., Al-Abri, S., Huntington, S. et al. Symptomatic Exposures Among California Inmates 2011–2013. J. Med. Toxicol. 11, 309–316 (2015). https://doi.org/10.1007/s13181-014-0456-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-014-0456-6

Keywords

Navigation